9-99221683-G-C

Variant summary

Our verdict is Uncertain significance. Variant got 3 ACMG points: 3P and 0B. PM2PP3

The NM_033087.4(ALG2):​c.212C>G​(p.Ala71Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000306 in 1,568,990 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).

Frequency

Genomes: 𝑓 0.000053 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000028 ( 0 hom. )

Consequence

ALG2
NM_033087.4 missense

Scores

2
7
10

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:4

Conservation

PhyloP100: 1.28
Variant links:
Genes affected
ALG2 (HGNC:23159): (ALG2 alpha-1,3/1,6-mannosyltransferase) This gene encodes a member of the glycosyltransferase 1 family. The encoded protein acts as an alpha 1,3 mannosyltransferase, mannosylating Man(2)GlcNAc(2)-dolichol diphosphate and Man(1)GlcNAc(2)-dolichol diphosphate to form Man(3)GlcNAc(2)-dolichol diphosphate. Defects in this gene have been associated with congenital disorder of glycosylation type Ih (CDG-Ii). Alternative splicing results in multiple transcript variants. [provided by RefSeq, Nov 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 3 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.794

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ALG2NM_033087.4 linkc.212C>G p.Ala71Gly missense_variant Exon 1 of 2 ENST00000476832.2 NP_149078.1 Q9H553-1A0A024R184
ALG2NR_024532.2 linkn.260C>G non_coding_transcript_exon_variant Exon 1 of 3
ALG2XM_047423996.1 linkc.-636C>G upstream_gene_variant XP_047279952.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ALG2ENST00000476832.2 linkc.212C>G p.Ala71Gly missense_variant Exon 1 of 2 1 NM_033087.4 ENSP00000417764.1 Q9H553-1
ALG2ENST00000238477.5 linkn.212C>G non_coding_transcript_exon_variant Exon 1 of 3 2 ENSP00000432675.2 A0A0A0MTE0

Frequencies

GnomAD3 genomes
AF:
0.0000525
AC:
8
AN:
152242
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000121
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000441
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000232
AC:
4
AN:
172310
Hom.:
0
AF XY:
0.0000209
AC XY:
2
AN XY:
95832
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000344
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0000725
Gnomad SAS exome
AF:
0.0000384
Gnomad FIN exome
AF:
0.000115
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000282
AC:
40
AN:
1416748
Hom.:
0
Cov.:
32
AF XY:
0.0000199
AC XY:
14
AN XY:
702356
show subpopulations
Gnomad4 AFR exome
AF:
0.0000306
Gnomad4 AMR exome
AF:
0.0000497
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.0000528
Gnomad4 SAS exome
AF:
0.0000363
Gnomad4 FIN exome
AF:
0.0000521
Gnomad4 NFE exome
AF:
0.0000265
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
AF:
0.0000525
AC:
8
AN:
152242
Hom.:
0
Cov.:
33
AF XY:
0.0000134
AC XY:
1
AN XY:
74382
show subpopulations
Gnomad4 AFR
AF:
0.000121
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000441
Gnomad4 OTH
AF:
0.00
Bravo
AF:
0.0000604
ExAC
AF:
0.0000261
AC:
3

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Uncertain:1
Apr 23, 2020
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

Variant summary: ALG2 c.212C>G (p.Ala71Gly) results in a non-conservative amino acid change located in the N-terminal domain (IPR028098) of the encoded protein sequence. Three of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 2.3e-05 in 172310 control chromosomes (gnomAD v2). The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. To our knowledge, no occurrence of c.212C>G in individuals affected with Congenital Disorder of Glycosylation, Type 1i and no experimental evidence demonstrating its impact on protein function have been reported. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as uncertain significance. -

Inborn genetic diseases Uncertain:1
Jan 18, 2023
Ambry Genetics
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

The c.212C>G (p.A71G) alteration is located in exon 1 (coding exon 1) of the ALG2 gene. This alteration results from a C to G substitution at nucleotide position 212, causing the alanine (A) at amino acid position 71 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

ALG2-congenital disorder of glycosylation;C4015597:Congenital myasthenic syndrome 14 Uncertain:1
Oct 18, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This sequence change replaces alanine, which is neutral and non-polar, with glycine, which is neutral and non-polar, at codon 71 of the ALG2 protein (p.Ala71Gly). This variant is present in population databases (rs551744220, gnomAD 0.008%). This variant has not been reported in the literature in individuals affected with ALG2-related conditions. ClinVar contains an entry for this variant (Variation ID: 917751). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

not provided Uncertain:1
Nov 04, 2019
GeneDx
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

Has not been previously published as pathogenic or benign to our knowledge; Not observed at a significant frequency in large population cohorts (Lek et al., 2016); In silico analysis, which includes protein predictors and evolutionary conservation, supports that this variant does not alter protein structure/function -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.21
BayesDel_addAF
Benign
-0.20
T
BayesDel_noAF
Benign
-0.33
CADD
Uncertain
24
DANN
Uncertain
0.98
DEOGEN2
Uncertain
0.56
D
Eigen
Benign
0.18
Eigen_PC
Benign
0.14
FATHMM_MKL
Benign
0.67
D
LIST_S2
Uncertain
0.95
D
M_CAP
Pathogenic
0.52
D
MetaRNN
Pathogenic
0.79
D
MetaSVM
Benign
-0.33
T
MutationAssessor
Uncertain
2.0
M
PrimateAI
Uncertain
0.65
T
PROVEAN
Uncertain
-2.5
N
REVEL
Uncertain
0.29
Sift
Benign
0.082
T
Sift4G
Benign
0.13
T
Polyphen
0.89
P
Vest4
0.47
MutPred
0.42
Gain of sheet (P = 0.0827);
MVP
0.77
MPC
0.46
ClinPred
0.28
T
GERP RS
4.7
Varity_R
0.51
gMVP
0.69

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.030
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs551744220; hg19: chr9-101983965; API